Results for tag: "Dazoxiben"

Dazoxiben is a hematological drug used to treat chronic myeloid leukemia (CML). It is a tyrosine kinase inhibitor (TKI) that works by blocking the activity of the BCR-ABL protein, which is responsible for the uncontrolled growth of CML cells. Dazoxiben is typically used in combination with other drugs, such as imatinib, to treat CML. It is also used to treat other hematological disorders, such as polycythemia vera and essential thrombocythemia. The dazoxiben market is a rapidly growing segment of the hematological drugs market. It is expected to benefit from the increasing prevalence of CML and other hematological disorders, as well as the growing demand for more effective treatments. The market is also expected to benefit from the development of new drugs and the introduction of new technologies. Some of the major companies in the dazoxiben market include Novartis, Pfizer, Bristol-Myers Squibb, Merck, and AstraZeneca. Show Less Read more